Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways

Approval of checkpoint inhibitors for treatment of metastatic triple negative breast cancer (mTNBC) has opened the door for the use of immunotherapies against this disease. However, not all patients with mTNBC respond to current immunotherapy approaches such as checkpoint inhibitors. Recent evidence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michelle M. Williams (Autor), Sabrina A. Hafeez (Autor), Jessica L. Christenson (Autor), Kathleen I. O'Neill (Autor), Nia G. Hammond (Autor), Jennifer K. Richer (Autor)
Formato: Libro
Publicado: MDPI AG, 2021-11-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible